Global Radiopharmaceutical Theranostics Market
Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) — The “Radiopharmaceutical Theranostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product Type, Radioisotope, Source, Application, Indication, and End User” report has been added to ResearchAndMarkets.com’s providing.
The international radiopharmaceutical theranostics market is projected to witness substantial progress, reaching $3,441.97 million by 2028 from $1,814.58 million in 2022, with a sturdy Compound Annual Growth Rate (CAGR) of 11.3% in the course of the interval from 2022 to 2028.
The market’s growth is pushed by the growing incidence of most cancers and the rising utility of radiopharmaceutical theranostics in treating cardiovascular problems.
Radiopharmaceuticals play an important function in each the analysis and remedy of most cancers, making them a cornerstone within the combat in opposition to this illness. They allow clinicians to diagnose particular varieties and levels of most cancers, offering important info for remedy planning. Moreover, radiopharmaceuticals are integral to focused therapies, making certain exact and efficient remedy whereas minimizing hurt to wholesome tissues.
The adoption of radiopharmaceutical theranostics has expanded into numerous areas of medication. For occasion, they’re now utilized in treating cardiovascular problems. The mixture of therapeutic and diagnostic methods, often called theranostics, has paved the best way for personalised medication. It has allowed for extra tailor-made and efficient remedies, akin to radionuclide remedy for superior prostate most cancers and neuroendocrine tumors.
While the market holds important progress potential, regulatory challenges associated to the approval of radiopharmaceutical theranostics stay a hurdle. Nevertheless, the rising prevalence of most cancers worldwide and the promising purposes of radiopharmaceutical theranostics in personalised medication proceed to drive market progress.
Companies Mentioned
-
Bayer AG
-
GE HealthCare Technologies Inc
-
Curium
-
Lantheus Medical Imaging, Inc.
-
Telix Pharmaceuticals Ltd.
-
Cardinal Health Inc
-
Advanced Accelerator Applications S.A.
-
Jubilant Radiopharma
-
Theragnostics
-
NuView Life Sciences
Key Market Insights:
-
Product Type: The positron emission tomography (PET) tracers phase is predicted to register the best CAGR in the course of the forecast interval. PET tracers provide increased decision and quantification of exercise, making them a most well-liked selection for imaging methods.
-
Radioisotope: Lutetium (Lu) 177 is anticipated to witness the best CAGR. It is more and more utilized in focused radionuclide remedy for most cancers, together with prostate most cancers and neuroendocrine tumors.
-
Source: Cyclotrons are anticipated to dominate the supply phase. They are well-suited for producing radionuclides utilized in medical imaging methods, significantly PET.
-
Application: The oncology phase is more likely to maintain the biggest market share. Radiopharmaceutical theranostics have a major impression on most cancers remedy, providing focused therapeutic options for numerous kinds of most cancers.
-
End User: Hospitals presently dominate the market. However, tutorial and analysis institutes are anticipated to develop on the highest CAGR in the course of the forecast interval, pushed by analysis actions and technological developments.
The international radiopharmaceutical theranostics market is poised for substantial progress, pushed by the growing prevalence of most cancers and the increasing purposes of radiopharmaceuticals in personalised medication.
Key Attributes:
|
Report Attribute |
Details |
|
No. of Pages |
185 |
|
Forecast Period |
2022 – 2028 |
|
Estimated Market Value (USD) in 2022 |
$1814.58 million |
|
Forecasted Market Value (USD) by 2028 |
$3441.97 million |
|
Compound Annual Growth Rate |
11.3% |
|
Regions Covered |
Global |
Key Topics Covered:
1. Introduction
2. Radiopharmaceutical Theranostics Market – Key Takeaways
3. Research Methodology
4. Radiopharmaceutical Theranostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert’s Opinion
5. Radiopharmaceutical Theranostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Cancer
5.1.2 Rising Application in Treatment of Cardiovascular Disorders
5.2 Market Restraints
5.2.1 Regulatory Challenges for Approval of Radiopharmaceutical Theranostics
5.3 Market Opportunities
5.3.1 Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies
5.4 Future Trends
5.4.1 Radiopharmaceutical Theranostics in Nuclear Medicine
5.5 Impact Analysis
6. Radiopharmaceutical Theranostics Market – Global Analysis
6.1 Global Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis
6.2 Global Radiopharmaceutical Theranostics Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
6.3.1 GE HealthCare Technologies Inc
6.3.2 Curium
7. Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Product Type
7.1 Overview
7.2 Global Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
7.2.1 Positron Emission Tomography (PET) Tracers
7.2.1.1 Overview
7.2.1.2 Positron Emission Tomography (PET) Tracers: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
7.2.2 Beta Emitters
7.2.2.1 Overview
7.2.2.2 Beta Emitters: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
7.2.3 Alpha Emitters
7.2.3.1 Overview
7.2.3.2 Alpha Emitters: Global Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Radiopharmaceutical Theranostics Market Analysis – by Radioisotope
9. Global Radiopharmaceutical Theranostics Market Analysis – by Source
10. Global Radiopharmaceutical Theranostics Market Analysis – by Application
11. Global Radiopharmaceutical Theranostics Market Analysis – by Indication
12. Global Radiopharmaceutical Theranostics Market Analysis – by End User
13. Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – Geographic Analysis
14. Impact Of COVID-19 Pandemic on Radiopharmaceutical Theranostics Market
15. Radiopharmaceutical Theranostics Market – Industry Landscape
15.1 Overview
15.2 Growth Strategies within the Radiopharmaceutical Theranostics Market
15.3 Inorganic Growth Strategies
15.3.1 Overview
15.4 Organic Growth Strategies
15.4.1 Overview
16. Company Profiles
For extra details about this report go to https://www.researchandmarkets.com/r/m4s6ot
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s main supply for worldwide market analysis experiences and market information. We offer you the latest information on worldwide and regional markets, key industries, the highest firms, new merchandise and the latest traits.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
